Paul Kohlhaas from Molecule at ARDD2023: Public Markets for IP: First Lessons Financing Longevity...

Paul Kohlhaas, Co-Founder & CEO Molecule, Switzerland presents at the 10th Aging Research and Drug Discovery conference: Public Markets for IP: First Lessons Financing Longevity Research via Decentralised Science